List view / Grid view
Here, EPR explores some highlights of the UK’s new Life…
Here, EPR explores some highlights of the UK’s new Life Sciences Vision for the pharma, biopharma and biotech industries, covering topics from funding to regulatory reviews and clinical trial innovation.
The MHRA have approved Ronapreve as the first monoclonal antibody…
The MHRA have approved Ronapreve as the first monoclonal antibody combination product for the treatment of COVID-19 infection in the UK.
A fund of almost £450 million has been announced by…
A fund of almost £450 million has been announced by the UK Government to mitigate drug shortages in the event of a no-deal Brexit.
